Diodos, Ruel P.
HRN: 17-42-27 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/24/2022
12/01/2022
IV
1.5gms
Q6
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes